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Risk-based eradication as a control 
measure to limit the spread of LA-
MRSA among Danish pig herds – a 
simulation study
Jana Schulz  1,2, Anette Boklund3, Nils toft1 & tariq Halasa3
A national screening in 2016 identified 88% of Danish pig herds positive for livestock-associated 
Methicillin-resistant Staphylococcus aureus (LA-MRSA). This highlights the importance of evaluating 
potential control measures that could reduce the prevalence of LA-MRSA among Danish pig herds. In 
addition to describing the effects of (1) reduced within-herd transmission, (2) increased biosecurity, and 
(3) movement restrictions, the eradication of LA-MRSA as a potential control measure was investigated 
using a simulation model mimicking the spread of LA-MRSA among pig herds between 2006 and 2015. 
The latter strategy was simulated either as eradication of a random selection of herds for surveillance 
or as a risk-based selection of herds based on their potential to spread LA-MRSA via pig movements in 
four different scenarios: low- vs. high-prevalence scenarios with control measures starting in 2007 and 
in 2010. Almost all control measures showed the potential to reduce the spread of LA-MRSA among 
pig herds, especially when implemented intensively and when control measures were combined. 
Risk-based selection of herds for eradication led to a greater relative reduction compared to random 
selection. In the high-prevalence scenario in particular, combinations including risk-based eradication 
led to the greatest relative reduction.
Within the pig population, livestock-associated Methicillin-resistant Staphylococcus aureus (LA-MRSA) is an 
opportunistic pathogen that does not usually cause clinical signs and thus no treatment is required. However, 
transmission from pigs to humans can occur1. Under unfavourable conditions, LA-MRSA can cause severe infec-
tions that might be hard to treat in humans because LA-MRSA is resistant to a wide range of antibiotics. To limit 
the risk of LA-MRSA spreading from pigs to humans, an effective strategy to control LA-MRSA within pig herds 
is needed.
The prevalence of LA-MRSA-positive herds in Denmark has increased dramatically since 2006, reaching 88% 
in 20162. A national action plan was therefore established in 2015 to control LA-MRSA in pig herds. Among 
other control measures, the plan aims to reduce the use of antibiotics by 15%3. However, such a reduction might 
not be sufficient as recent research results have shown that drastic reductions in antibiotic use are needed to limit 
LA-MRSA spread4,5. These reductions might not be realistic in industrialised farms, and other measures must 
therefore be sought.
A simulation model mimicking the spread and control of LA-MRSA among Danish pig herds between 2006 
and 2015 investigated the effects of the following control measures and combinations thereof on LA-MRSA 
spread among pig herds5,6: (1) a reduction in herds using high-risk antibiotics such as tetracyclines and β-lactams, 
i.e. modelling herds with reduced within-herd prevalence, (2) increased biosecurity, i.e. assuming a reduced prob-
ability of indirect LA-MRSA transmission via humans, (3) movement restrictions, i.e. prohibiting the movement 
of pigs from LA-MRSA-positive to LA-MRSA-negative pig herds, and (4) eradication of LA-MRSA in 5–7.5% 
of the herds tested positive for LA-MRSA. Only intensive control programmes that combined the four control 
options showed good potential for limiting the spread of LA-MRSA among pig herds5. However, the observed 
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prevalence in Denmark in 2016 was substantially higher than the scenarios investigated by Schulz et al.5. It is 
therefore important to evaluate the success of these measures under a high initial prevalence, and to study the 
effect of other control options that may aid in the control of LA-MRSA in Danish pig herds.
Pig movements were shown to be a driving factor in the spread of LA-MRSA6–9. Based on herd-specific char-
acteristics, herds could be categorised by their potential to spread a pathogen via pig movements. The size of the 
out-going contact chain is defined as the number of herds that could potentially receive pigs from one specific 
herd either (1) directly via pig movements from another herd, or (2) indirectly via other pig herds, within a 
certain time period and taking into account the temporal order of pig movements10. It could be used to identify 
herds with a greater potential to spread a pathogen via pig movements due to the higher number of contacts11,12. 
An eradication process focusing on these herds might prove useful, given the unrealistically high economic losses 
associated with eradicating the bacteria from all positive herds with the current high prevalence13.
Using the original model by Schulz et al.5,6, this study aims to evaluate the effect of risk-based eradication, 
i.e. in herds with a greater potential to spread LA-MRSA (hereafter referred to as hubs for LA-MRSA spread). 
Additionally, we investigated (1) the influence of the initial between-herd prevalence (at national level) when 
initiating a control programme (low-prevalence vs. high-prevalence scenario), and (2) the effects of a later initi-
ation (2007 vs. 2010) in both the low- and high-prevalence scenarios on the potential of each individual control 
measure and their combinations to reduce the spread of LA-MRSA among pig herds.
Materials and Methods
The following two chapters briefly explain the original model and describe in detail the enhancements made to 
carry out the presented study. All processes and parameters were described in detail in Schulz et al.6 and Schulz 
et al.5. Each model run was repeated 250 times, which was deemed sufficient for the model to converge and cover 
the variability in the simulated scenarios. The model was programmed in R version 3.2.2. - “Fire Safety”14.
Simulation model. Herd information from 12,874 active Danish pig herds and 993,474 registered pig move-
ments among these herds were used in an agent-based simulation model mimicking the spread and control of 
LA-MRSA among Danish pig herds between January 2006 and December 20155,6. For each herd, a unique identi-
fication number, the herd type (breeding and multiplier herd, production herd, weaner herd, organic pig herd or 
hobby herd), and the number of registered sows, weaners and finishers were available. Herd types and herd sizes 
were assumed to be constant during a considered simulation year and were updated on each 1st January according 
to the initial data set.
In the original model, within-herd spread was modelled as a three-compartment SIS model (sow-, weaner-, 
and finisher-compartment). Transmission between the compartments was modelled mimicking the high-risk 
transmission routes following the production line (e.g. from the sow to weaner and from the weaner to finisher 
compartments) as well as low-risk transmission routes to mimic the spread of LA-MRSA not related to the pro-
duction process (e.g. via contaminated equipment). Thus, a set of three transmission parameters was used for 
each herd, where higher transmission rates were assumed for herds using high-risk antimicrobials such as tetra-
cyclines and β-lactams6.
To mimic the between-herd spread, transmission was modelled via pig movements or via indirect contact 
among pig herds. Pig movements were registered in the Central Husbandry Register (CHR) and consisted of the 
date of the movement, the number of pigs moved (batch size), and the unique identification numbers of the send-
ing and receiving herds. If the sender was LA-MRSA negative, no pig movement was modelled as transmission 
was not possible. If the sending herd was LA-MRSA positive, the number of positive pigs in the movement batch 
was estimated based on the within-herd prevalence. The number of LA-MRSA-positive pigs in the receiving herd 
was updated and thus an increased prevalence was simulated.
Indirect transmission among pig herds was modelled via two routes: (1) humans visiting more than one pig 
herd per day, and (2) trucks collecting pigs for slaughter. The number of indirect contacts was calculated based on 
a Poisson distribution. As no data were available for humans visiting pig herds, the mean (lambda) for the Poisson 
distribution was estimated as described elsewhere5,15. Data on the collection of pigs sent for slaughter were availa-
ble in the movement register and used to calculate a herd-specific lambda for abattoir movements. The probability 
of transmission via both humans and trucks was modelled as PERT distributions based on expert opinions6.
Two default scenarios were established: for the low-prevalence scenario, LA-MRSA was introduced by ran-
dom selection of 400 production herds and 10 breeding and multiplier herds on 1st January 2006 and again on 
1st January 20096. In the high-prevalence scenario, 10,000 herds were selected at random and independent of the 
registered herd type to be LA-MRSA positive on 26th December 2006.
control strategies. Four control measures were implemented in the original study5: (1) reduced within-herd 
spread of LA-MRSA in 50% or 100% of the herds, mimicking the termination of use of high-risk antibiotics in 
these herds (Scenario acronyms: AB (50%) and AB (100%)), (2) reduced probability of indirect transmission of 
LA-MRSA via humans by 50% or 75%, mimicking increased biosecurity in all herds (Scenario acronyms: ProbIT 
(50%) and ProbIT (75%)), (3) movement restrictions prohibiting the movement of pigs from LA-MRSA-positive 
to LA-MRSA-negative herds based on testing all herds once or four times per year (Scenario acronyms: MR (1/
year) and MR (4/year)), and (4) eradication of LA-MRSA (i.e. sending pigs for slaughter, cleaning and disinfect-
ing the facilities and re-stocking with LA-MRSA-negative pigs) in randomly selected herds tested positive for 
LA-MRSA (Scenario acronym: EradR).
In the random eradication process, 7.5% of the breeding and multiplier herds and 5% of all other herd types 
were randomly selected to initiate the eradication process after testing positive for LA-MRSA in the simulation. 
During the eradication process, no pig movements were simulated. If pig movements were registered during the 
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eradication period, these movements were ignored. The duration of the eradication was dependent on the herd 
type and number of animals within the herd4.
To model a risk-based eradication process, we enhanced the original data set by adding the size of the 
out-going contact chain, which involved counting the number of herds that received pigs from the respective 
herd directly or indirectly via pig movements within the considered year. When LA-MRSA screening was simu-
lated, positive herds were arranged in order according to the size of their out-going contact chain, and 7.5% of the 
breeding and multiplier herds and 5% of the other herd types with the highest values of out-going contact chain 
were chosen for initiating the eradication process (Scenario acronym: EradH).
All control measures were initiated individually and combined in all possible combinations. To enable com-
parison between two scenarios, the relative reduction was calculated as the proportion Rs for each scenario s, as 
follows:
=
−R Prev Prev
Prevs
d s
d
where Prevs is the predicted median prevalence of scenario s and Prevd is the predicted median prevalence of the 
default scenario. The effects of control measures were measured six years after the initiation of control to enable 
comparison between the different scenarios.
Results
Effects of an early initiation of control. A low- and a high-prevalence scenario were set up in this study 
to allow evaluation of their influence on the effects of control measures. Table 1 shows the predicted prevalence 
in both scenarios on 1st January 2007 and 1st January 2010 (on the potential start day of control). We observed 
an increase in the predicted median herd prevalence in the low-prevalence scenario between 2007 and 2010. In 
contrast, in the high-prevalence scenario, the predicted median herd prevalence decreased slightly, even without 
active control measures (Table 1).
Scenario 
description
Date of prevalence 
estimate
Low-prevalence scenario: Predicted 
median herd prevalence (in %) [90% 
prediction interval]
High-prevalence scenario: 
Predicted median herd prevalence 
(in %) [90% prediction interval]
Early initiation 1st January 2007 3 [3–5] 67 [66–68]
Late initiation 1st January 2010 20 [17–25] 62 [60–63]
Table 1. Predicted median herd prevalence at the start of the control measures for early and late initiation and 
in the low- and high-prevalence scenarios.
Scenario 
ID
Scenario 
acronym Scenario description
Predicted median herd prevalence in %* [90% prediction interval] (relative 
reduction)
Early initiation of control Late initiation of control
Low-prevalence 
scenario
High-prevalence 
scenario
Low-prevalence 
scenario
High-prevalence 
scenario
0 No control 47 [42–52] 69 [67–71] 62 [59–65] 71 [69–73] (0%)
1.1 AB (50%) Termination of use of high-risk antibiotics in 50% of the herds 47 [30–60] (0%) 65 [55–74] (5%) 59 [46–70] (6%) 66 [60–75] (7%)
1.2 AB (100%) Termination of use of high-risk antibiotics in 100% of the herds 29 [13–44] (38%) 60 [38–69] (13%) 48 [26–60] (24%) 61 [41–74] (14%)
1.3 ProbIT (50%) Probability of indirect transmission via humans reduced by 50% 37 [31–43] (21%) 67 [66–69] (2%) 57 [52–60] (9%) 70 [68–71] (2%)
1.4 ProbIT (75%) Probability of indirect transmission via humans reduced by 75% 31 [26–37] (33%) 66 [65–68] (4%) 53 [48–57] (15%) 69 [67–70] (3%)
1.5 MR (1/year) Movement restrictions based on testing all herds once per year 47 [43–53] (0%) 62 [60–64] (10%) 63 [60–66] (−1%) 64 [62–65] (10%)
1.6 MR (4/year) Movement restrictions based on testing all herds four times per year 37 [32–42] (22%) 63 [60–65] (9%) 55 [51–58] (12%) 64 [62–66] (9%)
1.7 EradR (1/year) Eradication in randomly selected herds 43 [38–49] (8%) 65 [63–67] (6%) 59 [55–62] (6%) 67 [64–68] (6%)
1.8 EradH (1/year) Risk-based eradication 33 [27–37] (31%) 57 [54–59] (18%) 49 [44–52] (22%) 57 [55–60] (20%)
Table 2. Predicted median herd prevalence of the default scenarios run without any control measures (first 
row) and relative reductions (in brackets) observed for the individual control measures six years after initiation 
of control (early initiation: predictions on 31st December 2012, late initiation: predictions on 31st December 
2015). The initiation date of control measures is dependent on the respective scenario (early initiation: onset 
on 1st January 2007, late initiation: onset on 1st January 2010). Scenarios with the lowest (highest) predicted 
relative reduction are marked italic (bold) for each scenario. *Results presented in Schulz et al.5 except results 
for scenario EradH.
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To allow for comparison between the low- and high-risk scenarios, previously published results of the 
low-prevalence scenario were included to this manuscript, again. Control measures were initiated on 1st January 
2007 in both the low- and high-risk scenarios. When the measures were implemented individually, a reduction 
in the use of high-risk antibiotics in all herds led to a relative reduction of 38% in the predicted herd prevalence 
in the low-prevalence scenario (Scenario 1.2, Table 2). In the high-prevalence scenario, eradication of hubs led 
to the greatest reduction (18%) in predicted herd prevalence (Scenario 1.8, Table 2). Two control measures did 
not lead to any reduction in the low-prevalence scenario: a reduction in high-risk antimicrobials in 50% of the 
herds (Scenario 1.1, Table 2) and movement restrictions based on testing all herds once per year (Scenario 1.5, 
Table 2). Reducing the probability of transmission related to indirect contact by 75% as an indicator of increased 
levels of biosecurity (Scenario 1.4, Table 2) led to the second greatest reduction rate in the low-prevalence sce-
nario. In contrast, in the high-prevalence scenario, increased levels of biosecurity led to a worse performance 
independent of the chosen reduction proportion (Table 2). In general, the relative reduction rates observed in the 
high-prevalence scenario were smaller than the obtained reductions in the low-prevalence scenario, except for 
the two scenarios where no reduction was observed in the low-prevalence scenario. The risk-based eradication 
process clearly led to greater reduction rates compared to the random eradication process in both the low- and 
high-prevalence scenarios.
When combining two control measures, the observed reduction rates varied from 0% (Scenario 2.3) to 83% 
(Scenario 2.24) in the low-prevalence scenario (Table 3). With the exception of two scenarios, the predicted 
relative reduction was smaller in the high-prevalence scenario compared to the low-prevalence scenario. The 
observed reduction rates varied from 8% (Scenario 2.1) to 65% (Scenario 2.24) in the high-prevalence scenario. 
Scenarios including risk-based eradication led to the greatest reduction rates.
The combination of three control measures increased the maximum reduction rate to 94% (Scenario 3.24, 
Table 4) in the low-prevalence scenario. In all scenarios, the relative reduction was greater in the low-prevalence 
scenario compared to the high-prevalence scenario, where the reduction rates ranged from 15% (Scenario 3.3) to 
Scenario 
ID Scenario acronym
Predicted median herd prevalence in %* [90% prediction interval] (relative reduction)
Early initiation of control Late initiation of control
Low-prevalence 
scenario
High-prevalence 
scenario
Low-prevalence 
scenario High-prevalence scenario
0 No control 47 [42–52] 69 [67–71] 62 [59–65] 71 [69–73] (0%)
2.1
AB (50%)
ProbIT (50%) 36 [22–49] (24%) 64 [54–73] (8%) 52 [39–64] (16%) 66 [55–74] (7%)
2.2 ProbIT (75%) 30 [17–42] (37%) 63 [52–71] (9%) 49 [36–60] (22%) 65 [55–73] (9%)
2.3 MR (1/year) 47 [30–61] (0%) 57 [48–65] (17%) 59 [48–70] (5%) 58 [48–65] (19%)
2.4 MR (4/year) 35 [22–50] (25%) 59 [48–68] (15%) 51 [38–63] (17%) 61 [50–65] (15%)
2.5 EradR (1/year) 42 [26–56] (10%) 61 [51–70] (11%) 55 [41–67] (12%) 63 [57–67] (12%)
2.6 EradH (1/year) 33 [17–45] (31%) 52 [41–62] (24%) 44 [31–57] (29%) 53 [46–66] (26%)
2.7
AB (100%)
ProbIT (50%) 22 [11–35] (54%) 56 [31–67] (19%) 41 [23–55] (34%) 60 [26–72] (16%)
2.8 ProbIT (75%) 15 [7–26] (68%) 58 [37–63] (16%) 38 [22–50] (40%) 58 [39–69] (19%)
2.9 MR (1/year) 30 [15–46] (36%) 50 [42–59] (27%) 48 [28–63] (22%) 52 [34–58] (27%)
2.10 MR (4/year) 21 [9–33] (56%) 52 [35–59] (25%) 38 [20–50] (39%) 51 [37–62] (28%)
2.11 EradR (1/year) 26 [11–40] (45%) 55 [36–66] (20%) 41 [24–57] (34%) 55 [32–67] (23%)
2.12 EradH (1/year) 15 [6–28] (68%) 44 [12–52] (37%) 29 [11–43] (54%) 40 [20–52] (44%)
2.13
ProbIT (50%)
MR (1/year) 38 [32–43] (19%) 60 [58–62] (13%) 58 [53–61] (8%) 62 [60–64] (13%)
2.14 MR (4/year) 28 [23–33] (41%) 61 [59–63] (12%) 49 [44–53] (22%) 63 [61–65] (12%)
2.15 EradR (1/year) 33 [28–39] (29%) 62 [61–64] (9%) 52 [48–56] (16%) 65 [63–66] (9%)
2.16 EradH (1/year) 23 [19–27] (52%) 53 [51–55] (23%) 40 [34–45] (36%) 52 [50–55] (26%)
2.17
ProbIT (75%)
MR (1/year) 32 [27–39] (31%) 58 [57–60] (15%) 54 [49–58] (14%) 61 [59–63] (15%)
2.18 MR (4/year) 23 [19–29] (50%) 59 [57–59] (14%) 45 [40–49] (28%) 62 [60–64] (13%)
2.19 EradR (1/year) 28 [23–34] (41%) 61 [59–63] (12%) 48 [42–52] (24%) 63 [61–65] (11%)
2.20 EradH (1/year) 18 [15–22] (62%) 50 [48–52] (27%) 34 [29–39] (45%) 49 [46–51] (32%)
2.21
MR (1/year)
EradR (1/year) 29 [25–34] (37%) 57 [55–59] (18%) 46 [42–49] (26%) 58 [56–60] (19%)
2.22 EradH (1/year) 26 [22–30] (46%) 52 [50–54] (24%) 42 [38–46] (33%) 53 [51–55] (26%)
2.23
MR (4/year)
EradR (4/year) 21 [18–25] (55%) 45 [43–47] (35%) 36 [32–40] (42%) 45 [43–47] (37%)
2.24 EradH (4/year) 8 [7–10] (83%) 24 [23–26] (65%) 16 [14–20] (74%) 21 [18–23] (71%)
Table 3. Predicted median herd prevalence of the default scenarios run without any control measures (first 
row) and relative reductions observed for the combinations of two control measures six years after initiation of 
control (early initiation: predictions on 31st December 2012, late initiation: predictions on 31st December 2015). 
The initiation date of control measures is dependent on the respective scenario (early initiation: onset on 1st 
January 2007, late initiation: onset on 1st January 2010). Scenario acronyms are explained in the main text and 
in Table 2. Scenarios with the lowest (greatest) predicted relative reduction are marked italic (bold) for each 
scenario. *Results presented in Schulz et al.5 except scenarios including EradH.
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82% (Scenario 3.24, Table 4). Finally, when combining all four control measures (Table 5), the greatest observed 
reduction rate in the low-prevalence scenario was 97%, while in the high-prevalence scenario it was 88%.
Effects of a late initiation of control. The initiation of control measures was simulated on 1st January 
2010 (late initiation of control) in both the low- and high-prevalence scenarios.
When initiating control in 2010, the effects of individual control measures are comparable to the effects 
observed in the early-initiation scenario for both the low- and high-prevalence scenarios (Table 2). However, 
lower levels were observed in all scenarios with individual control measures, with the exception of a reduction 
in high-risk antibiotics in 50% of the herds in the low-prevalence scenario. Nevertheless, in the high-prevalence 
scenario, a later initiation of control led to a similar or a slightly greater predicted relative reduction. When 
control measures were combined, both the smallest and the greatest relative reduction rates were found in the 
same scenarios as in the respective low- or high-prevalence scenario with early initiation of control measures 
(Tables 3–5). However, in contrast to the low-prevalence scenario, in which the relative reduction decreased with 
a late initiation of control, most relative reduction values in the high-prevalence scenario remained constant or 
increased slightly in the late-initiation scenario. In all scenarios, the risk-based selection of herds for eradication 
Scenario 
ID Scenario acronym
Predicted median herd prevalence in %* [90% prediction interval] (relative 
reduction)
Early initiation of control Late initiation of control
Low-prevalence 
scenario
High-prevalence 
scenario
Low-prevalence 
scenario
High-prevalence 
scenario
0 No control 47 [42–52] 69 [67–71] 62 [59–65] 71 [69–73] (0%)
3.1
AB (50%)
ProbIT (50%)
MR (1/year) 36 [22–49] (23%) 55 [47–63] (20%) 53 [40–65] (14%) 56 [47–64] (21%)
3.2 MR (4/year) 26 [16–38] (44%) 56 [45–64] (19%) 44 [32–56] (29%) 57 [47–65] (19%)
3.3 EradR (1/year) 32 [19–46] (31%) 59 [48–68] (15%) 48 [34–61] (23%) 61 [49–70] (14%)
3.4 EradH (1/year) 21 [11–34] (54%) 50 [40–57] (27%) 36 [23–48] (43%) 46 [34–58] (35%)
3.5
ProbIT (75%)
MR (1/year) 32 [20–43] (33%) 54 [44–61] (22%) 50 [38–61] (20%) 54 [46–63] (24%)
3.6 MR (4/year) 21 [13–33] (55%) 55 [44–64] (21%) 40 [28–50] (36%) 56 [45–65] (22%)
3.7 EradR (1/year) 26 [15–38] (44%) 57 [46–68] (18%) 44 [31–55] (30%) 58 [48–68] (19%)
3.8 EradH (1/year) 16 [8–27] (66%) 43 [36–55] (37%) 29 [19–41] (53%) 42 [33–52] (41%)
3.9
MR (1/year)
EradR (1/year) 29 [18–41] (39%) 53 [43–61] (24%) 42 [32–53] (32%) 55 [45–59] (23%)
3.10 EradH (1/year) 24 [13–36] (48%) 47 [38–57] (31%) 37 [25–49] (40%) 48 [42–57] (33%)
3.11
MR (4/year)
EradR (4/year) 20 [11–31] (57%) 42 [31–50] (40%) 32 [21–42] (48%) 39 [33–51] (45%)
3.12 EradH (4/year) 8 [3–14] (84%) 20 [11–27] (71%) 13 [7–22] (80%) 15 [9–21] (79%)
3.13
AB (100%)
ProbIT (50%)
MR (1/year) 22 [10–35] (53%) 50 [40–56] (27%) 42 [25–56] (32%) 48 [18–55] (32%)
3.14 MR (4/year) 15 [7–25] (68%) 52 [34–60] (28%) 33 [14–44] (48%) 50 [26–61] (30%)
3.15 EradR (1/year) 38 [32–43] (61%) 50 [37–64] (25%) 35 [20–49] (43%) 51 [28–61] (28%)
3.16 EradH (1/year) 11 [4–20] (77%) 51 [11–46] (45%) 22 [10–32] (65%) 34 [12–45] (52%)
3.17
ProbIT (75%)
MR (1/year) 19 [7–30] (59%) 38 [41–54] (30%) 38 [22–49] (39%) 47 [19–55] (34%)
3.18 MR (4/year) 13 [6–22] (72%) 48 [18–58] (31%) 29 [16–39] (53%) 48 [22–58] (33%)
3.19 EradR (1/year) 15 [5–26] (68%) 49 [32–58] (29%) 31 [16–43] (50%) 51 [24–61] (29%)
3.20 EradH (1/year) 8 [3–15] (83%) 36 [27–45] (48%) 18 [9–27] (71%) 31 [12–40] (57%)
3.21
MR (1/year)
EradR (1/year) 16 [8–28] (65%) 46 [33–53] (34%) 30 [15–41] (52%) 45 [28–53] (37%)
3.22 EradH (1/year) 13 [5–22] (72%) 38 [28–47] (44%) 24 [11–34] (61%) 36 [23–45] (50%)
3.23
MR (4/year)
EradR (4/year) 10 [4–18] (79%) 32 [19–43] (53%) 21 [10–31] (67%) 30 [15–40] (58%)
3.24 EradH (4/year) 3 [1–6] (94%) 12 [6–18] (82%) 6 [2–10] (91%) 6 [2–11] (91%)
3.25
ProbIT (50%)
MR (1/year)
EradR (1/year) 21 [17–25] (55%) 54 [52–56] (22%) 39 [34–42] (38%) 55 [53–57] (22%)
3.26 EradH (1/year) 18 [14–22] (62%) 48 [46–50] (30%) 34 [29–38] (46%) 48 [46–50] (32%)
3.27
MR (4/year)
EradR (4/year) 15 [12–17] (69%) 41 [39–43] (41%) 29 [25–33] (53%) 40 [38–42] (43%)
3.28 EradH (4/year) 5 [4–6] (90%) 19 [18–21] (72%) 11 [7–13] (83%) 14 [12–15] (81%)
3.29
ProbIT (75%)
MR (1/year)
EradR (1/year) 17 [14–21] (64%) 52 [50–54] (24%) 34 [29–39] (46%) 53 [51–55] (25%)
3.30 EradH (1/year) 14 [11–17] (70%) 46 [44–48] (33%) 29 [24–33] (54%) 45 [43–47] (37%)
3.31
MR (4/year)
EradR (4/year) 12 [9–14] (75%) 39 [37–41] (44%) 25 [21–29] (60%) 37 [35–40] (48%)
3.32 EradH (4/year) 4 [3–5] (92%) 17 [16–18] (76%) 8 [7–10] (87%) 11 [9–12] (85%)
Table 4. Predicted median herd prevalence of the default scenarios run without any control measure (first 
row) and relative reductions observed for the combinations of three control measures six years after initiation 
of control (early initiation: predictions on 31st December 2012, late initiation: predictions on 31st December 
2015). The initiation date of control measures is dependent on the respective scenario (early initiation: onset on 
1st January 2007, late initiation: onset on 1st January 2010). Scenario acronyms are explained in the main text 
and in Table 2. Scenarios with the lowest (greatest) predicted relative reduction are marked italic (bold) for each 
scenario. *Results presented by Schulz et al.5 except scenarios including EradH.
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led to greater reduction rates compared to the randomly selected herds. For all simulated initial prevalence and 
control initiation scenarios, the greatest reduction was observed in Scenario 4.16, in which all control measures 
were combined in their most intensive versions. Even in the high-prevalence scenario with late initiation of con-
trol measures, a relative reduction of 95% was observed (Table 5) and the 90% prediction interval was similar to 
the low-prevalence scenario with late initiation of control measures.
Discussion
A simulation model mimicking the spread and control of LA-MRSA among Danish pig herds between 2006 
and 2015 was enhanced by an additional control measure: eradication of LA-MRSA in herds selected based on 
their risk of spreading LA-MRSA via pig movements. The effects of this risk-based eradication were calculated 
for four scenarios with different levels of initial prevalence (low-prevalence vs. high-prevalence scenarios) and 
the date when the control measures were initiated (early- vs. late-initiation scenario). The four potential control 
measures (reduced use of high-risk antibiotics (in 50% or 100% of the herds), increased biosecurity (by 50% or 
75%), movement restrictions (based on testing herds once or four times per year), and eradication (random or 
risk-based selection of herds) were evaluated individually and combined to investigate their potential for reduc-
ing LA-MRSA spread 6 years after their initiation. Almost all control measures showed potential for reducing the 
LA-MRSA herd prevalence, with greater reduction rates when control measures were combined. Control meas-
ures were not sufficient to clear LA-MRSA from all herds within 6 years of initiation in any of the tested scenar-
ios (regarding initial LA-MRSA prevalence and initiation date of control). Risk-based eradication led to greater 
reduction rates when implemented individually and in all tested control measure combinations, independent of 
the considered prevalence and initiation scenario.
Eradication of LA-MRSA in positive herds could reduce the predicted herd prevalence. This effect might even 
increase when eradication is combined with movement restrictions, limiting the risk of re-introduction via pig 
movements. Only 7.5% of the breeding and multiplier herds and 5% of the other herd types were assumed to 
start the eradication process, as depopulation and re-stocking of more herds might lead to ethical and economic 
issues. Selecting herds randomly might result in fewer administrative costs, as risk-based selection would require 
updated information on the size of the out-going contact chain of each herd that tested positive for LA-MRSA. 
Given that information on pig movements is available in the Danish pig movement database, and calculating the 
size of out-going contact chains is reasonably straightforward, the risk-based approach could be relatively easily 
implemented.
The combination of a reduction in the use of high-risk antimicrobials (and thus of decreased transmission 
rates) in all herds and increasing biosecurity by 75% led to a reduction of 68% in the low-prevalence scenario with 
early initiation of control (Scenario 2.8, Table 3). This example also showed that the combination of two control 
measures that were not based on testing all herds indicated a high reduction potential when implemented at a low 
Scenario 
ID Scenario acronym
Predicted median herd prevalence in %* [90% prediction interval] (relative 
reduction)
Early initiation of control Late initiation of control
Low-prevalence 
scenario
High-prevalence 
scenario
Low-prevalence 
scenario
High-prevalence 
scenario
0 No control 47 [42–52] 69 [67–71] 62 [59–65] 71 [69–73] (0%)
4.1
AB (50%) ProbIT (50%)
MR (1/year)
EradR (1/year) 20 [12–30] (56%) 49 [41–57] (29%) 34 [24–44] (45%) 50 [42–57] (30%)
4.2 EradH (1/year) 17 [9–27] (64%) 40 [35–52] (42%) 28 [18–39] (54%) 42 [31–51] (41%)
4.3
MR (4/year)
EradR (4/year) 13 [8–22] (72%) 36 [27–46] (47%) 25 [16–34] (61%) 34 [24–44] (52%)
4.4 EradH (4/year) 4 [2–8] (91%) 14 [10–22] (80%) 8 [4–13] (87%) 10 [5–16] (86%)
4.5
AB (50%) ProbIT (75%)
MR (1/year)
EradR (1/year) 16 [9–24] (65%) 48 [38–56] (31%) 30 [21–38] (53%) 48 [38–57] (33%)
4.6 EradH (1/year) 13 [7–20] (73%) 41 [32–49] (41%) 25 [15–33] (61%) 38 [28–49] (46%)
4.7
MR (4/year)
EradR (4/year) 11 [6–16] (77%) 35 [27–43] (49%) 21 [13–30] (66%) 33 [23–41] (53%)
4.8 EradH (4/year) 3 [1–6] (93%) 13 [9–19] (81%) 6 [3–10] (91%) 7 [4–13] (90%)
4.9
AB (100%) ProbIT (50%)
MR (1/year)
EradR (1/year) 11 [5–19] (77%) 43 [29–50] (38%) 23 [14–33] (62%) 41 [27–49] (42%)
4.10 EradH (1/year) 9 [4–15] (82%) 35 [27–43] (50%) 18 [8–27] (71%) 31 [19–39] (56%)
4.11
MR (4/year)
EradR (4/year) 7 [3–13] (86%) 30 [14–37] (57%) 16 [6–24] (74%) 25 [14–33] (64%)
4.12 EradH (4/year) 2 [1–4] (96%) 9 [2–13] (87%) 4 [1–7] (93%) 5 [1–7] (94%)
4.13
AB (100%) ProbIT (75%)
MR (1/year)
EradR (1/year) 9 [5–15] (80%) 37 [30–46] (46%) 21 [11–29] (66%) 39 [25–46] (45%)
4.14 EradH (1/year) 7 [3–12] (86%) 34 [22–43] (51%) 15 [7–22] (76%) 29 [13–36] (60%)
4.15
MR (4/year)
EradR (4/year) 6 [2–10] (86%) 28 [25–35] (59%) 13 [5–19] (79%) 22 [10–30] (68%)
4.16 EradH (4/year) 1 [1–3] (97%) 9 [6–11] (88%) 3 [1–5] (95%) 4 [1–5] (95%)
Table 5. Predicted median herd prevalence of the default scenarios (first row) and relative reductions observed 
for the combinations of four control measures six years after initiation of control (early initiation: predictions on 
31st December 2012, late initiation: predictions on 31st December 2015). The initiation date of control measures 
is dependent on the respective scenario (early initiation: onset on 1st January 2007, late initiation: onset on 
1st January 2010). Scenario acronyms are explained in the main text and in Table 2. Scenarios with the lowest 
(greatest) predicted relative reduction are marked italic (bold) for each scenario. *Results presented by Schulz et 
al.5 except scenarios including EradH.
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herd prevalence. However, in the high-prevalence scenario, only the combination of movement restrictions and 
risk-based eradication based on testing all herds four times per year led to a comparable reduction rate of 65% 
with the early initiation of control (71% with late initiation of control) (Scenario 2.24, Table 3) when combining 
two control measures.
When combining four control measures, all 16 combinations showed reduction rates equal to or above 50% 
in the low-prevalence scenario with early initiation of control, whereas in the high-prevalence scenario with early 
initiation of control, 8 out of 16 control scenarios showed reduction rates equal to or above 50%. Both examples 
highlight the importance of adapting control measures to the current LA-MRSA prevalence in the considered 
region/country to ensure a successful effect.
Eradication, as well as other control measures, lead to costs for the respective pig herds and it is therefore 
important to examine the cost-effectiveness of the simulated strategies. This would enable a better evaluation of 
these control measures, as the effectiveness and the costs of a potential control programme both represent essen-
tial aspects of the decision-making process.
The effect of the reduction in the use of high-risk antimicrobials is closely related to the reduced within-herd 
transmission rates that were assumed in case that a herd terminates the use of tetracyclines and β-lactams6,16. Any 
intervention strategy that would reduce within-herd transmission rates might lead to similar effects.
In the current study, we simulated high initial prevalence scenarios in order to study the effectiveness of 
control measures under the current high herd prevalence situation in Denmark. In the absence of information 
regarding future movement data, we used historical movement data for the simulations. If future movement and 
contact patterns are substantially different from the historical data, then the results of these measures might also 
be different. Nevertheless, Schultz et al.12 studied the movement patterns in Danish pig herds over the simulated 
period of time and showed that the patterns were quite consistent over time, which supports the assumptions in 
this study.
In this study, we repeated scenarios that have been presented earlier4. These scenarios were supplemented 
with new control measures and a higher level of initial prevalence. We find it important to present all scenarios so 
that the reader has a full overview of the effectiveness of the control measures and the extra contribution of newly 
simulated control scenarios, as well as the effect of all scenarios under a high initial prevalence level.
In conclusion, all tested control measures showed potential to reduce the spread of LA-MRSA among Danish 
pig herds to different degrees. Risk-based eradication led to greater reduction rates compared to random selec-
tion of herds during the eradication process. In the high-prevalence scenario, combinations of control measures 
including risk-based eradication clearly indicated a more considerable reduction potential than the random selec-
tion of herds.
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